Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
‘Highly Problematic’: Acting FDA Commissioner Paused Planned OK Of Novavax Shot
Apr 04 2025
•
By
Sarah Karlin-Smith
Novavax was expected to finally nab full approval of its COVID-19 vaccine on 1 April.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from US FDA
More from Vaccines